Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.83 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | KIF11 | P52732 | 1/20 | 0.52 |
| ▸ | TGM2 | P21980 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7733701 | 0.91 | L3MBTL1 (1.00) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL18086475 | 0.85 | L3MBTL1 (0.59) | L3MBTL1MAPTTDP1POLBNPC1 | |
| SCHEMBL17368411 | 0.83 | KIF11 (0.58) | L3MBTL1MAPTCA12CA1CA2 | |
| SCHEMBL1176666 | 0.83 | L3MBTL1 (0.83) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL18033762 | 0.83 | L3MBTL1 (0.83) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL8777217 | 0.83 | L3MBTL1 (0.83) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL1422823 | 0.83 | L3MBTL1 (0.83) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL1176999 | 0.82 | L3MBTL1 (0.73) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL11245302 | 0.82 | L3MBTL1 (0.55) | L3MBTL1MAPTALDH1A1TDP1POLB | |
| SCHEMBL15270323 | 0.81 | L3MBTL1 (0.79) | L3MBTL1MAPTALDH1A1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954705-A | Indole derivative and preparation method thereof | 南阳师范学院 | 2025-05-09 | — | — | CN | claimed |
| US-20260056161-A1 | THIN LAYER TYPE ELECTROCHEMICAL SYSTEM INCLUDING SALT BRIDGE AND ELECTROCHEMICAL ANALYSIS METHOD USING THE SAME | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2026-02-26 | — | — | US | disclosed |
| CN-119954705-A | Indole derivative and preparation method thereof | 南阳师范学院 | 2025-05-09 | — | — | CN | disclosed |
| CN-113912529-B | Method for synthesizing indole compounds by catalyzing N-aryl amide compounds and vinylene carbonate with ruthenium | 成都大学 | 2023-07-25 | — | — | CN | disclosed |
| WO-2023109912-A1 | 3, 4-DIHYDROISOQUINOLIN-1 (2H) -ONES DERIVATIVES AS STING ANTAGONISTS AND THE USE THEREOF | BEIGENE, LTD. (KY) | 2023-06-22 | — | — | WO | disclosed |
| US-11680074-B2 | Compounds, functionalised dioxaborolane or dioxaborinane derivatives, method for preparing same and uses thereof | ECOLE SUPERIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS (FR) | 2023-06-20 | — | — | US | disclosed |
| WO-2023033271-A1 | THIN FILM-TYPE ELECTROCHEMICAL SYSTEM COMPRISING SALT BRIDGE AND ELECTROCHEMICAL ANALYSIS METHOD USING SAME | 서울대학교산학협력단 | 2023-03-09 | — | — | WO | disclosed |
| EP-3464300-B1 | NOVEL COMPOUNDS, FUNCTIONALISED DIOXABOROLANE OR DIOXABORINANE DERIVATIVES, METHOD FOR PREPARING SAME AND USES THEREOF | ECOLE SUPERIEURE DE PHYSIQUE ET CHIMIE IND DE LA VILLE DE PARIS (FR) | 2021-12-01 | — | — | EP | disclosed |
| WO-2021130638-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | CARNA BIOSCIENCES, INC. (JP) | 2021-07-01 | — | — | WO | disclosed |
| EP-3412660-B9 | SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | EA PHARMA CO LTD (JP) | 2021-04-14 | — | — | EP | disclosed |
| US-6303780-B1 | 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same | DUPONT PHARMACEUTICALS COMPANY | 2001-10-16 | — | — | US | disclosed |
| US-6140499-A | 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same | DUPONT PHARMACEUTICAL COMPANY (US) | 2000-10-31 | — | — | US | disclosed |
| EP-0929533-A1 | 4,4-DISUBSTITUTED-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS AND INTERMEDIATES AND PROCESSES FOR MAKING THE SAME | Du Pont Pharmaceuticals Company (US) | 1999-07-21 | — | — | EP | disclosed |
| US-5874430-A | COMPOUNDS AS PROTEASE, REVERSE TRANSCRIPTASE INHIBITORS FOR DIAGNOSIS | DUPONT PHARMACEUTICALS COMPANY (US) | 1999-02-23 | — | — | US | disclosed |
| WO-1998014436-A1 | 4,4-DISUBSTITUTED-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS AND INTERMEDIATES AND PROCESSES FOR MAKING THE SAME | DUPONT PHARMACEUTICALS COMPANY (US) | 1998-04-09 | — | — | WO | disclosed |
| US-5633218-A | CONTROLLING WEEDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-05-27 | — | — | US | disclosed |
| US-5631206-A | Herbicidal heteroaryl substituted anilides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-05-20 | — | — | US | disclosed |
| EP-0722441-A1 | HERBICIDAL HETEROARYL SUBSTITUTED ANILIDES | E.I. DU PONT DE NEMOURS & COMPANY INCORPORATED (US) | 1996-07-24 | — | — | EP | disclosed |
| EP-0619804-B1 | HERBICIDAL ACYLATED AMINO-(PHENYL- OR PYRIDINYL- OR THIENYL-)-PHENYL DERIVATIVES | DU PONT (US) | 1996-05-22 | — | — | EP | disclosed |
| WO-1995009846-A1 | HERBICIDAL HETEROARYL SUBSTITUTED ANILIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260056161-A1 | THIN LAYER TYPE ELECTROCHEMICAL SYSTEM INCLUDING SALT BRIDGE AND ELECTROCHEMICAL ANALYSIS METHOD USING THE SAME | SLC9A2, SLC9A3, SLC9A1 | L3MBTL1 4802/4885MAPT 3154/4885ALDH1A1 2045/4885 |
| US-11680074-B2 | Compounds, functionalised dioxaborolane or dioxaborinane derivatives, method for preparing same and uses thereof | RDX, XDH, NOX4 | L3MBTL1 3728/4885MAPT 4464/4885ALDH1A1 944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.